Procyrion
PrivateLast Round
Series E
Feb 5, 2024
Total Funding Raised
$115.2M
Company Overview
Procyrion is a medical device company specializing in innovative circulatory support solutions for patients with acute decompensated heart failure who are resistant to diuretics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Procyrion Comps
Public and private peers based on sector, stage, and business model.
Procyrion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Feb 5, 2024 | ||||
| Series D | Jul 9, 2019 | ||||
| Series C | Jan 30, 2018 | ||||
| Series B | Oct 9, 2015 | ||||
| Grant | Jan 23, 2014 |
Procyrion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scientific Health Development | Series B, Series D, Series C |
| Fannin Innovation Studio | Series D, Series C, Series E, Seed |
| Texas Emerging Technology Fund | Series D, Series C |
| Bluebird Ventures | Series E, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2025
Andrew Davis appointed as the new Chief Commercial Officer.
Procyrion Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Procyrion's valuation, stock price, and market status.
